Tech Company Financing Transactions
AdoRx Therapeutics Funding Round
CRT Pioneer Fund and Epidarex Capital invested in a $10 million funding round for AdoRx Therapeutics. The financing round was recorded on 6/22/2018.
Transaction Overview
Company Name
Announced On
6/22/2018
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Undisclosed
Investors
Epidarex Capital (Liz Roper)
Proceeds Purpose
The company will focus on the discovery of new modulators of the adenosine pathway for the treatment of cancer.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
137a George St.
Edinburgh, EH2 4JY
UK
Edinburgh, EH2 4JY
UK
Phone
Website
Email Address
Overview
AdoRx Therapeutics is pursuing the discovery of new therapeutics for cancer based on modulation of the adenosine pathway. High levels of adenosine in the tumour microenvironment enable cancer to evade the immune system.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Peter Finan
Browse more venture capital transactions:
Prev: 6/22/2018: Inky venture capital transaction
Next: 6/22/2018: Whistle Sports Network venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs